KROS - Keros Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
15.63 -0.9 (-5.76%)	---	---	0.32 (2.19%)	-0.63 (-4.03%)	-0.52 (-3.47%)	0.33 (2.29%)	0.33 (2.29%)

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.76
Diluted EPS:: -0.76
Basic P/E:: -19.3816
Diluted P/E:: -19.3816
RSI(14) 1m:: 100.0
VWAP:: 14.73
RVol:: 13.4287

Events

Period	Kind	Movement	Occurred At
Day	Rvol 10 increase day	rvol 10.01, 14.59 -1.04 (-6.65%)	Oct 15 14:03
1m	Price increase 1m	14.93 +0.15 (+1.05%)	Oct 15 12:41
1m	Price decrease 1m	14.55 -0.22 (-1.52%)	Oct 15 12:24
1m	Price increase 1m	14.64 +0.16 (+1.1%)	Oct 15 11:45
Day	Rvol 5 increase day	rvol 5.01, 14.34 -1.3 (-8.29%)	Oct 15 10:39